Assessment of perioperative pulmonary fluid volume using remote dielectric sensing (ReDS<sup>TM</sup>) non-invasive lung fluid measurement technology in transcatheter tricuspid valve-in-valve implantation: The first case report_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

LONG Yuliang , ZHANG Yuan , ZHANG Xiaochun , WANG Peng , CUI Xiaotong ,  PAN Wenzhi ,  ZHOU Daxin , GE Junbo

Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, 200032, P. R. China;

Corresponding author：

PAN Wenzhi, Email: peden@sina.com; ZHOU Daxin, Email: zhou.daxin@zs-hospital.sh.cn

Keywords：

Tricuspid regurgitation; transcatheter tricuspid valve replacement; remote dielectric sensing; lung fluid volume; case report

DOI：

10.7507/1007-4848.202401045

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

One of its primary surgical treatments of tricuspid regurgitation is tricuspid valve biological valve replacement. Catheter tricuspid valve-in-valve implantation is a novel interventional alternative for biological valve failure. The non-invasive lung fluid measuring device remote dielectric sensing (ReDS^TM) has been increasingly incorporated into clinical practice as a means of monitoring chronic heart failure in recent years. This report describes the process and outcomes of the first instance of perioperative lung fluid volume evaluation following transcatheter tricuspid valve implantation utilizing ReDS^TM technology. The patient has a short-term, substantial increase in postoperative lung fluid volume as compared to baseline.

1.	Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2021, 77(4): 450-500.
2.	Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
3.	周达新, 潘文志, 吴永健, 等. 经导管主动脉瓣置换术中国专家共识(2020更新版). 中国介入心脏病学杂志, 2020, 28(6): 301-309.Zhou DX, Pan WZ, Wu YJ, et al. Expert consensus on transcatheter aortic valve implantation in China (2020 updated version). Chin J Interv Cardiol, 2020, 28(6): 301-309.
4.	中国医师协会心血管内科医师分会结构性心脏病学组. 单纯主动脉瓣经股动脉主动脉瓣置换中国专家共识2023. 中国介入心脏病学杂志, 2023, 31(11): 801-810.Structural Heart Disease Group of the Chinese Society of Cardiovascular Physicians. Expert consensus on transfemoral transcatheter aortic valve replacement for isolated aortic stenosis in China 2023. Chin J Interv Cardiol, 2023, 31(11): 801-810.
5.	陈思, 李宁, 王伟, 等. LuX-Valve经导管三尖瓣置换系统血流动力学分析. 中国心血管病研究, 2023, 21(3): 235-239.Chen S, Li N, Wang W, et al. Hemodynamic analysis of the LuX-valve transcatheter tricuspid valve replacement system. Chin J Cardiovasc Res, 2023, 21(3): 235-239.
6.	Ning X, Cao J, Wang W, et al. 4-year follow-up after transatrial transcatheter tricuspid valve replacement with the LuX-valve. J Cardiovasc Dev Dis, 2022, 9(12): 435.
7.	Sun Z, Li H, Zhang Z, et al. Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation. EuroIntervention, 2021, 17(10): 818-826.
8.	Lu FL, Ma Y, An Z, et al. First-in-man experience of transcatheter tricuspid valve replacement with LuX-valve in high-risk tricuspid regurgitation patients. JACC Cardiovasc Interv, 2020, 13(13): 1614-1616.
9.	李兰兰, 金屏, 刘洋, 等. 国产球囊扩张式瓣膜经导管“瓣中瓣”治疗三尖瓣生物瓣衰败的临床应用. 中国胸心血管外科临床杂志, 2021, 28(8): 908-914.Li LL, Jin P, Liu Y, et al. Preliminary exploration of the domestic balloon-expandable valve in the treatment of degenerated tricuspid bioprosthetic valve via transcatheter "valve-in-valve" technology. Chin J Clin Thorac Cardiovasc Surg, 2021, 28(8): 908-914.
10.	Kay JK, Maselli-Campagna G, Tsuji KK. Surgical treatment of tricuspid insufficiency. Ann Surg, 1965, 162: 53-58.
11.	Abraham WT, Bensimhon D, Pinney SP, et al. Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trial. ESC Heart Fail, 2021, 8(5): 3472-3482.
12.	Amir O, Ben-Gal T, Weinstein JM, et al. Evaluation of remote dielectric sensing (ReDS) technology-guided therapy for decreasing heart failure re-hospitalizations. Int J Cardiol, 2017, 240: 279-284.
13.	Uriel N, Sayer G, Imamura T, et al. Relationship between noninvasive assessment of lung fluid volume and invasively measured cardiac hemodynamics. J Am Heart Assoc, 2018, 7(22): e009175.
14.	Wilcox CS, Testani JM, Pitt B. Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure. Hypertension, 2020, 76(4): 1045-1054.
15.	Amir O, Azzam ZS, Gaspar T, et al. Validation of remote dielectric sensing (ReDS™) technology for quantification of lung fluid status: Comparison to high resolution chest computed tomography in patients with and without acute heart failure. Int J Cardiol, 2016, 221: 841-846.
16.	Lala A, Barghash MH, Giustino G, et al. Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions. ESC Heart Fail, 2021, 8(2): 1047-1054.
17.	Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging, 2019, 12(3): 433-442.
18.	Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol, 2004, 43(3): 405-409.
19.	Taramasso M, Benfari G, van der Bijl P, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol, 2019, 74(24): 2998-3008.

1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2021, 77(4): 450-500.
2. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
3. 周达新, 潘文志, 吴永健, 等. 经导管主动脉瓣置换术中国专家共识(2020更新版). 中国介入心脏病学杂志, 2020, 28(6): 301-309.Zhou DX, Pan WZ, Wu YJ, et al. Expert consensus on transcatheter aortic valve implantation in China (2020 updated version). Chin J Interv Cardiol, 2020, 28(6): 301-309.
4. 中国医师协会心血管内科医师分会结构性心脏病学组. 单纯主动脉瓣经股动脉主动脉瓣置换中国专家共识2023. 中国介入心脏病学杂志, 2023, 31(11): 801-810.Structural Heart Disease Group of the Chinese Society of Cardiovascular Physicians. Expert consensus on transfemoral transcatheter aortic valve replacement for isolated aortic stenosis in China 2023. Chin J Interv Cardiol, 2023, 31(11): 801-810.
5. 陈思, 李宁, 王伟, 等. LuX-Valve经导管三尖瓣置换系统血流动力学分析. 中国心血管病研究, 2023, 21(3): 235-239.Chen S, Li N, Wang W, et al. Hemodynamic analysis of the LuX-valve transcatheter tricuspid valve replacement system. Chin J Cardiovasc Res, 2023, 21(3): 235-239.
6. Ning X, Cao J, Wang W, et al. 4-year follow-up after transatrial transcatheter tricuspid valve replacement with the LuX-valve. J Cardiovasc Dev Dis, 2022, 9(12): 435.
7. Sun Z, Li H, Zhang Z, et al. Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation. EuroIntervention, 2021, 17(10): 818-826.
8. Lu FL, Ma Y, An Z, et al. First-in-man experience of transcatheter tricuspid valve replacement with LuX-valve in high-risk tricuspid regurgitation patients. JACC Cardiovasc Interv, 2020, 13(13): 1614-1616.
9. 李兰兰, 金屏, 刘洋, 等. 国产球囊扩张式瓣膜经导管“瓣中瓣”治疗三尖瓣生物瓣衰败的临床应用. 中国胸心血管外科临床杂志, 2021, 28(8): 908-914.Li LL, Jin P, Liu Y, et al. Preliminary exploration of the domestic balloon-expandable valve in the treatment of degenerated tricuspid bioprosthetic valve via transcatheter "valve-in-valve" technology. Chin J Clin Thorac Cardiovasc Surg, 2021, 28(8): 908-914.
10. Kay JK, Maselli-Campagna G, Tsuji KK. Surgical treatment of tricuspid insufficiency. Ann Surg, 1965, 162: 53-58.
11. Abraham WT, Bensimhon D, Pinney SP, et al. Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trial. ESC Heart Fail, 2021, 8(5): 3472-3482.
12. Amir O, Ben-Gal T, Weinstein JM, et al. Evaluation of remote dielectric sensing (ReDS) technology-guided therapy for decreasing heart failure re-hospitalizations. Int J Cardiol, 2017, 240: 279-284.
13. Uriel N, Sayer G, Imamura T, et al. Relationship between noninvasive assessment of lung fluid volume and invasively measured cardiac hemodynamics. J Am Heart Assoc, 2018, 7(22): e009175.
14. Wilcox CS, Testani JM, Pitt B. Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure. Hypertension, 2020, 76(4): 1045-1054.
15. Amir O, Azzam ZS, Gaspar T, et al. Validation of remote dielectric sensing (ReDS™) technology for quantification of lung fluid status: Comparison to high resolution chest computed tomography in patients with and without acute heart failure. Int J Cardiol, 2016, 221: 841-846.
16. Lala A, Barghash MH, Giustino G, et al. Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions. ESC Heart Fail, 2021, 8(2): 1047-1054.
17. Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging, 2019, 12(3): 433-442.
18. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol, 2004, 43(3): 405-409.
19. Taramasso M, Benfari G, van der Bijl P, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol, 2019, 74(24): 2998-3008.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Latest ArticlesAssessment of perioperative pulmonary fluid volume using remote dielectric sensing (ReDS^TM) non-invasive lung fluid measurement technology in transcatheter tricuspid valve-in-valve implantation: The first case report

Abstract Full text Figures/Tables Video References Cited by

Format

Content

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Latest ArticlesAssessment of perioperative pulmonary fluid volume using remote dielectric sensing (ReDSTM) non-invasive lung fluid measurement technology in transcatheter tricuspid valve-in-valve implantation: The first case report

Abstract Full text Figures/Tables Video References Cited by

Format

Content

Latest ArticlesAssessment of perioperative pulmonary fluid volume using remote dielectric sensing (ReDS^TM) non-invasive lung fluid measurement technology in transcatheter tricuspid valve-in-valve implantation: The first case report